ARCHIVES

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 37 No. 03 | January 21, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003

In Brief: President Proposes $1,994 Billion For NCI;

February 10, 1995

NCI Plans a Catalog Of Research Tools

April 30, 1999

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004